Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | EO1428 | 1.0 | uM | 1 | TNFb | 49.0 | 70 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 91.0 | 52 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 85.0 | 64 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 61.0 | 45 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 79.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 57.0 | 50 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 63.0 | 59 | |
RA2159 | PI103 | 0.1 | uM | 1 | TNFb | 43.5 | 38 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 72.5 | 62 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 66.0 | 56 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 68.5 | 50 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 76.0 | 51 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 72.0 | 45 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNFb | 62.5 | 52 | |
N2586 | PI103 | 0.1 | uM | 1 | TNFb | 48.0 | 37 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | TNFb | 62.0 | 56 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 51.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 49.5 | 48 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 49.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 47.0 | 66 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 36.0 | 39 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | TNFb | 41.5 | 50 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | TNFb | 50.5 | 56 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 45.5 | 52 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 38.0 | 60 |